Sociology of MedicineSociology of MedicineСоциология медицины1728-28102413-2942Eco-Vector66092310.17816/socm660923YNWZMIMEDICAL SOCIOLOGICAL STUDIESМЕДИКО-СОЦИОЛОГИЧЕСКИЕ ИССЛЕДОВАНИЯReview ArticleResearch focus on vital limitations of patients with inflammatory bowel diseasesИсследовательский фокус витальных ограничений пациентов с воспалительными заболеваниями кишечникаhttps://orcid.org/0009-0007-2180-88177916-2340DmitrievVyacheslav A.ДмитриевВячеслав Александрович
Russian Federation

MD, Cand. Sci. (Medicine)

канд. мед. наук

doctordmitriev@gmail.comhttps://orcid.org/0000-0003-1355-51634854-1094KromIrina L.КромИрина Львовна
Russian Federation

MD, Dr. Sci. (Medicine), Professor

д-р мед. наук, профессор

irina.crom@yandex.ruSaratov State Medical University named after V.I. RazumovskyСаратовский государственный медицинский университет им. В.И. Разумовского30062025201020252421081142502202513052025Copyright ©; 2025, Eco-VectorCopyright ©; 2025, Эко-Вектор2025Eco-VectorЭко-Векторhttps://rjsocmed.com/1728-2810/article/view/660923

Chronic diseases, whose burden is regarded as one of the major challenges for national healthcare systems, significantly affect quality of life and contribute to the formation of vital limitations in daily life. Crohn disease and ulcerative colitis are the most common forms of inflammatory bowel disease. Patients with inflammatory bowel diseases are forced to live with a long-term and severe illness; some symptoms persist even during clinical remission and negatively affect social relationships, as well as personal, professional, and everyday life. This study aimed to examine the vital limitations of patients with inflammatory bowel diseases based on scientific data. A systematic review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) methodology. Relevant publications were identified through the PubMed and eLIBRARY.RU databases for the period 2001–2024. The final analysis included 54 publications selected by keywords: соматические и социальные ограничения при воспалительных заболеваниях кишечника / somatic and social limitations in inflammatory bowel diseases, качество жизни / quality of life, бремя хронических заболеваний / the burden of chronic diseases, as well as by reference lists of retrieved articles. Inclusion criteria: original studies, literature reviews, and meta-analyses containing data on vital limitations in inflammatory bowel diseases. Case reports and expert opinions were excluded. Vital limitations of patients with inflammatory bowel diseases were examined from the perspective of the sociology of everyday life, where they are interpreted as barriers to daily living, and the sociology of medicine, which addresses the social perception of health, life with a chronic illness, and public attitudes toward the patient. Research studies highlight vital limitations arising in patients with inflammatory bowel diseases or treatment complications, encompassing various aspects of daily functioning. Given their impact on quality of life and clinical prognosis, these limitations should be considered in the development of a continuum of integrated medical and social care for patients with inflammatory bowel diseases.

Хронические заболевания, бремя которых рассматривается как одна из ведущих проблем национальных систем здравоохранения, существенно влияют на качество жизни и способствуют формированию витальных ограничений в повседневной жизни. Болезнь Крона и язвенный колит — наиболее распространённые формы воспалительных заболеваний кишечника. Пациенты с воспалительным заболеванием кишечника вынуждены жить с длительным и тяжёлым заболеванием; при этом некоторые симптомы сохраняются в период клинической ремиссии и негативно сказываются на социальных отношениях, личной, профессиональной и бытовой сферах жизни. Цель — рассмотреть витальные ограничения пациентов с воспалительными заболеваниями кишечника по данным литературы. Проведён систематический обзор по методологии PRISMA (Preferred reporting items for systematic reviews and meta-analyses). При отборе релевантных публикаций использованы базы данных PubMed и eLibrary.Ru за период 2001–2024 гг. В итоговый анализ включены 54 публикации, отобранные по ключевым словам: «соматические и социальные ограничения при воспалительных заболеваниях кишечника», «качество жизни», «бремя хронических заболеваний», «somatic and social limitations in inflammatory bowel diseases», «quality of life», «the burden of chronic diseases», а также по спискам литературы найденных источников. Критерии включения: оригинальные исследования, обзоры литературы и метаанализы, содержащие данные о витальных ограничениях при воспалительных заболеваниях кишечника. Исключены клинические случаи, авторские мнения. Витальные ограничения пациентов с воспалительными заболеваниями кишечника рассмотрены с позиций социологии повседневности, в рамках которой они трактуются как барьеры в повседневной жизни, а также социологии медицины, раскрывающей социальное восприятие здоровья, жизни с хроническим заболеванием и общественное отношение к пациенту. В научных исследованиях рассматриваются витальные ограничения, возникающие у пациентов с воспалительными заболеваниями кишечника или осложнениями лечения, охватывающие различные аспекты жизнедеятельности. Принимая во внимание их влияние на качество жизни и клинический прогноз, данные ограничения следует учитывать при формировании континуума интегрированной медико-социальной помощи пациентам с воспалительными заболеваниями кишечника.

inflammatory bowel diseasespatients’ vital limitationssocialization barriersquality of lifeвоспалительные заболевания кишечникавитальные ограничения пациентовбарьеры социализациикачество жизниМинистерство здравоохранения Российской ФедерацииMinistry of Health of the Russian Federation121051100308-8Stamboltsyan VSh, Bakulin IG, Aslanov BI, Kirillova AA. Inflammatory bowel diseases: epidemiology and risk factors (review). Koloproktologia. 2024;23(4(90)):148–158. doi: 10.33878/2073-7556-2024-23-4-148-158 EDN: HCMWEJMacdonald GG, Koehn C, Attara G, et al. Patient perspectives on the challenges and responsibilities of living with chronic inflammatory diseases: qualitative study. J Particip Med. 2018;10(4):e10815. doi: 10.2196/10815Künsebeck HW, Körber J, Freyberger H. Quality of life in patients with inflammatory bowel disease. Psychother Psychosom. 1990;54(2–3):110–116. doi: 10.1159/000288385Irvine EJ. Quality of life — measurement in inflammatory bowel disease. Scand J Gastroenterol Suppl. 1993;199:36–39. doi: 10.3109/00365529309098355Reshetnikov AV, Prisyazhnaya NV, Pavlov SV, et. al. Rheumatoid arthritis in the Russian Federation: sociological aspekts. Medical news of North Caucasus. 2019;14(2):374–376. doi: 10.14300/mnnc.2019.14092 EDN: XRPKZMReshetnikov A, Gevandova M, Prisyazhnaya N, Vyatkina N. The role of parents in their child's cancer diagnosis, treatment, rehabilitation, and socialization. Indian J Pediatr. 2024;91(1):30–34. doi: 10.1007/s12098-022-04387-7 EDN: CRZKBYPrisyazhnaya NV, Bobrovskaya ON, Kaletskiy EG. The analysis of problems of supporting long-term nursing of individuals who lost their ability to self-care in Russia. Problems of social hygiene, public health and history of medicine. 2023;31(4):578–586. doi: 10.32687/0869-866X-2023-31-4-578-586 EDN: ADATUUGuo X, Cai L, Cao Y, et al. New pattern of individualized management of chronic diseases: focusing on inflammatory bowel diseases and looking to the future. Front Med. 2023;10:1186143. doi: 10.3389/fmed.2023.1186143 EDN: PSCIQRTiles-Sar N, Neuser J, de Sordi D, et al. Psychological interventions for inflammatory bowel disease: a systematic review and component network meta-analysis protocol. BMJ Open. 2022;12(6):e056982. doi: 10.1136/bmjopen-2021-056982 EDN: LFKBGKLe Berre C, Peyrin-Biroulet L; SPIRIT-IOIBD study group. Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD. Gastroenterology. 2021;160(5):1452–1460.e21. doi: 10.1053/j.gastro.2020.10.065 EDN: JHJHXWZhuzhlova NYu, Krom IL, Sazanova GYu, Razdevilova OP. Trends in the organization of medical care in the context of social determinism chronic non-communicable diseases. Modern problems of science and education. 2015;(1):229. EDN: YTIBHJDvornikova KA, Bystrova EYu, Platonova ON, Nozdrachev AD. Risk factors and genetic prerequisites for the developmentof inflammatory bowel diseases: current status of the problem. Progress in physiological science. 2021;52(2):61–82. doi: 10.31857/S0301179821010045 EDN: ZUOEVSHolik D, Včev A, Milostić-Srb A, et al. The effect of daily physical activity on the activity of inflammatory bowel diseases in therapy-free patients. Acta Clin Croat. 2019;58(2):202–212. doi: 10.20471/acc.2019.58.02.02Park SK, Ko BM, Goong HJ, et al. Short health scale: a valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease. World J Gastroenterol. 2017;23(19):3530–3537. doi: 10.3748/wjg.v23.i19.3530Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135(6):1907–1913. doi: 10.1053/j.gastro.2008.09.012Mizuno H, Katashima M, Sakagami K, et al. Factors of self-care agency in patients with inflammatory bowel disease in Japan. Inflamm Intest Dis. 2024;9(1):103–114. doi: 10.1159/000538007 EDN: TVECSTKeefer L, Kiebles JL, Taft TH. The role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure. Inflamm Bowel Dis. 2011;17(2):614–620. doi: 10.1002/ibd.21314Napolitano D, Vellone E, Iovino P, et al. Self-care in patients affected by inflammatory bowel disease and caregiver contribution to self-care (IBD-SELF): a protocol for a longitudinal observational study. BMJ Open Gastroenterol. 2024;11(1):e001510. doi: 10.1136/bmjgast-2024-001510 EDN: VHGXUXNagahori M, Imai T, Nakashoji M, et al. A web-based survey on self-management for patients with inflammatory bowel disease in Japan. PLoS One. 2023;18(7):e0287618. doi: 10.1371/journal.pone.0287618 EDN: AEIBYKFawson S, Dibley L, Smith K, et al. Developing an online program for self-management of fatigue, pain, and urgency in inflammatory bowel disease: patients' needs and wants. Dig Dis Sci. 2022;67(7):2813–2826. doi: 10.1007/s10620-021-07109-9 EDN: PSYCDHLangbrandtner J, Steimann G, Reichel C, et al. Inflammatory bowel disease — challenges in the workplace and support for coping with disease. Rehabilitation. 2022;61(2):97–106. (In German) doi: 10.1055/a-1581-6497 EDN: HJUASKGremyakina DA. Sociology of everyday life — scientific analysis of "routine". Modern Society: Issues of Theory, Methodology, Methods of Social Research. 2022;1:162–170. EDN: HAMEPKBorrell-Carrió F, Suchman AL, Epstein RM. The biopsychosocial model 25 years later: principles, practice, and scientific inquiry. Ann Fam Med. 2004;2(6):576–582. doi: 10.1370/afm.245Wang Z, Lu Y, Li L, et al. Relationship between severity of gastrointestinal symptoms and anxiety symptoms in patients with chronic gastrointestinal disease: the mediating role of illness perception. Psychol Res Behav Manag. 2023;16:4921–4933. doi: 10.2147/PRBM.S429132 EDN: IJXGUWFourie S, Jackson D, Aveyard H. Living with inflammatory bowel disease: a review of qualitative research studies. Int J Nurs Stud. 2018;87:149–156. doi: 10.1016/j.ijnurstu.2018.07.017Plevinsky JM, Greenley RN, Fishman LN. Self-management in patients with inflammatory bowel disease: strategies, outcomes, and integration into clinical care. Clin Exp Gastroenterol. 2016;9:259–267. doi: 10.2147/CEG.S106302DuBois KE, Blake CE, Rudisill C, et al. Use of treatment and self-management methods: perspectives and decisions of patients with ulcerative colitis. Am J Lifestyle Med. 2024:15598276241243300. doi: 10.1177/15598276241243300 EDN: FXXWEPRadford SJ, McGing J, Czuber-Dochan W, Moran G. Systematic review: the impact of inflammatory bowel disease-related fatigue on health-related quality of life. Frontline Gastroenterol. 2020;12(1):11–21. doi: 10.1136/flgastro-2019-101355 EDN: ZQXSTGDittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res. 2004;56(2):157–170. doi: 10.1016/S0022-3999(03)00371-4Villoria A, García V, Dosal A, et al. Fatigue in out-patients with inflammatory bowel disease: Prevalence and predictive factors. PLoS One. 2017;12(7):e0181435. doi: 10.1371/journal.pone.0181435Czuber-Dochan W, Dibley LB, Terry H, et al. The experience of fatigue in people with inflammatory bowel disease: an exploratory study. J Adv Nurs. 2013;69(9):1987–1999. doi: 10.1111/jan.12060Woodward S, Dibley L, Coombes S, et al. Identifying disease-specific distress in patients with inflammatory bowel disease. Br J Nurs. 2016;25(12):649–660. doi: 10.12968/bjon.2016.25.12.649van Houtum L, Rijken M, Groenewegen P. Do everyday problems of people with chronic illness interfere with their disease management? BMC Public Health. 2015;15:1000. doi: 10.1186/s12889-015-2303-3 EDN: IXDBULLuo XP, Mao R, Chen BL, et al. Over-reaching beyond disease activity: the influence of anxiety and medical economic burden on health-related quality of life in patients with inflammatory bowel disease. Patient Prefer Adherence. 2016;11:23–31. doi: 10.2147/PPA.S118589Lovén Wickman U, Yngman-Uhlin P, Hjortswang H, et al. Self-care among patients with inflammatory bowel disease: an interview study. Gastroenterol Nurs. 2016;39(2):121–128. doi: 10.1097/SGA.0000000000000120Pihl-Lesnovska K, Hjortswang H, Ek AC, Frisman GH. Patients' perspective of factors influencing quality of life while living with Crohn disease. Gastroenterol Nurs. 2010;33(1):37–44; quiz 45–46. doi: 10.1097/SGA.0b013e3181cd49d0Akhmerova PS, Garaeva AR, Ogarev VV, Sirota NA. Cognitive component of anxiety about disease progression in patients with inflammatory bowel diseases. Topical issues of medical science. 2023;(1(1)):121–122. (In Russ.) EDN: XVBPYOGroshek J, Basil M, Guo L, et al. Media consumption and creation in attitudes toward and knowledge of inflammatory bowel disease: web-based survey. J Med Internet Res. 2017;19(12):e403. doi: 10.2196/jmir.7624Taft TH, Keefer L, Leonhard C, Nealon-Woods M. Impact of perceived stigma on inflammatory bowel disease patient outcomes. Inflamm Bowel Dis. 2009;15(8):1224–1232. doi: 10.1002/ibd.20864Taft TH, Bedell A, Naftaly J, Keefer L. Stigmatization toward irritable bowel syndrome and inflammatory bowel disease in an online cohort. Neurogastroenterol Motil. 2017;29(2):10.1111/nmo.12921. doi: 10.1111/nmo.12921Skrautvol K, Nåden D. Tolerance limits, self-understanding, and stress resilience in integrative recovery of inflammatory bowel disease. Holist Nurs Pract. 2017;31(1):30–41. doi: 10.1097/HNP.0000000000000189Taft TH, Keefer L. A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease. Clin Exp Gastroenterol. 2016;9:49–58. doi: 10.2147/CEG.S83533Taft TH, Ballou S, Bedell A, Lincenberg D. Psychological considerations and interventions in inflammatory bowel disease patient care. Gastroenterol Clin North Am. 2017;46(4):847–858. doi: 10.1016/j.gtc.2017.08.007Schoefs E, Vermeire S, Ferrante M, et al. What are the unmet needs and most relevant treatment outcomes according to patients with inflammatory bowel disease? A qualitative patient preference study. J Crohns Colitis. 2023;17(3):379–388. doi: 10.1093/ecco-jcc/jjac145 EDN: VOSUWGRomasenko LV, Makhov VM, Isaykina MA. Disorders of the anxiety-depressive spectrum in inflammatory bowel diseases (psychosomatic correlations). Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(4):9–13. doi: 10.17116/jnevro20191190419 EDN: MQIMBXMackner LM, Crandall WV. Long-term psychosocial outcomes reported by children and adolescents with inflammatory bowel disease. Am J Gastroenterol. 2005;100(6):1386–1392. doi: 10.1111/j.1572-0241.2005.41428.xBel LG, Vollebregt AM, Van der Meulen-de Jong AE, et al. Sexual dysfunctions in men and women with inflammatory bowel disease: the influence of IBD-related clinical factors and depression on sexual function. J Sex Med. 2015;12(7):1557–1567. doi: 10.1111/jsm.12913Wright EK, Kamm MA. Impact of drug therapy and surgery on quality of life in Crohn's disease: a systematic review. Inflamm Bowel Dis. 2015;21(5):1187–1194. doi: 10.1097/MIB.0000000000000271Ananthakrishnan AN, Gainer VS, Cai T, et al. Similar risk of depression and anxiety following surgery or hospitalization for Crohn's disease and ulcerative colitis. Am J Gastroenterol. 2013;108(4):594–601. doi: 10.1038/ajg.2012.471Williams-Hall R, Trennery C, Sully K, et al. A qualitative study to explore the symptoms and impacts of Crohn's disease and to develop the Crohn's disease diary. Qual Life Res. 2023;32(1):209–223. doi: 10.1007/s11136-022-03233-9 EDN: PYALKXLevenstein S, Li Z, Almer S, et al. Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96(6):1822–1830. doi: 10.1111/j.1572-0241.2001.03878.x EDN: BDIQRJDaniel JM. Young adults' perceptions of living with chronic inflammatory bowel disease. Gastroenterol Nurs. 2002;25(3):83–94. doi: 10.1097/00001610-200205000-00002Purc-Stephenson R, Bowlby D, Qaqish ST. "A gift wrapped in barbed wire" positive and negative life changes after being diagnosed with inflammatory bowel disease. Qual Life Res. 2015;24(5):1197–1205. doi: 10.1007/s11136-014-0843-0 EDN: GFWWWAFletcher PC, Schneider MA, Van Ravenswaay V, Leon Z. I am doing the best that I can!: living with inflammatory bowel disease and/or irritable bowel syndrome (part II). Clin Nurse Spec. 2008;22(6):278–285. doi: 10.1097/01.NUR.0000325382.99717.ac